Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.

Acta Pharmacol Sin · 2023 · PMC10462766 · PMID 37055532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In locally advanced rectal cancer, the loss of mismatch-repair genes was a highly significant biomarker of response to the anti-PD-1 inhibitor dostarlimab [ 56 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.